Comment
doi: 10.1001/jama.2016.9778.
Radiation Therapy Deviations in Trial of Locally Advanced Pancreatic Cancer [corrected]
Affiliations
- PMID: 27701653
- DOI: 10.1001/jama.2016.9778
Item in Clipboard
Comment
Radiation Therapy Deviations in Trial of Locally Advanced Pancreatic Cancer [corrected]
JAMA.
.
Erratum in
-
Error in Title.JAMA. 2016 Nov 8;316(18):1924. doi: 10.1001/jama.2016.17038. JAMA. 2016. PMID: 27784056 No abstract available.
No abstract available
Comment in
-
Radiation Therapy Deviations in Trial of Locally Advanced Prostate Cancer-Reply.JAMA. 2016 Oct 4;316(13):1409-1410. doi: 10.1001/jama.2016.9781. JAMA. 2016. PMID: 27701655 No abstract available.
Comment on
-
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):809-16. doi: 10.1016/j.ijrobp.2010.11.039. Epub 2011 Feb 1. Int J Radiat Oncol Biol Phys. 2012. PMID: 21277694 Free PMC article. Clinical Trial.
-
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324. JAMA. 2016. PMID: 27139057 Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
